Foundation Medicine & Chugai announce partnership with NCC

Japan |  News | 0 Comment | 13 Feb, 2020

Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the&nbs...Read more

Nippon Shinyaku inks new agreement for prostate cancer treatment

Japan |  News | 0 Comment | 12 Feb, 2020

Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a ...Read more

Japan suggests combined drug treatment for lung cancer

Japan |  News | 0 Comment | 11 Feb, 2020

Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel ap...Read more

Chugai collaborates with National Cancer Center

Japan |  News | 0 Comment | 10 Feb, 2020

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer C...Read more

Santen, Verily to develop unique ophthalmic devices

Japan |  News | 0 Comment | 07 Feb, 2020

Japan based Santen Pharmaceutical Co., Ltd. and US based Verily, an Alphabet company, have announced the establishment o...Read more

Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug

Japan |  News | 0 Comment | 03 Feb, 2020

Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical stud...Read more

Japan unveils herbal medicines to treat stomach disorders

Japan |  News | 0 Comment | 30 Jan, 2020

In a recent study researchers at Okayama University, Japan illustrate the potential of berberine, a herbal Chinese medic...Read more

Kitakyushu Hospital to initiate Senhance Digital Laparoscopy Program

Japan |  News | 0 Comment | 30 Jan, 2020

TransEnterix, Inc. a medical device company that is digitizing the interface between the surgeon and the patient to impr...Read more

AgeX accelerates hypoimmunogenic cells development in Japan

Japan |  News | 0 Comment | 31 Jan, 2020

US based AgeX Therapeutics, a biotechnology company developing therapeutics for human aging and regeneration, announced ...Read more

JT to market CORECTIM in Japan to treat atopic dermatitis

Japan |  News | 0 Comment | 30 Jan, 2020

Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (Torii) have announced that JT has received manufacturing and mark...Read more

Eisai and PGDx jointly start R&D of cancer genetics panel test

Japan |  News | 0 Comment | 29 Jan, 2020

Japanese firm Eisai Co., Ltd., has entered into a joint research and development agreement with Personal Genome Diagnost...Read more

Eisai’s DAYVIGO gets approval in Japan to treat insomnia

Japan |  News | 0 Comment | 28 Jan, 2020

Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered ...Read more

Sasakawa Health Foundation focuses on World Leprosy Day 2020

Japan |  News | 0 Comment | 25 Jan, 2020

Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons...Read more

Amgen Astellas Biopharma to become wholly owned Amgen affiliate

Japan |  News | 0 Comment | 28 Jan, 2020

Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of...Read more

Eisai gets approval of anti-epileptic drug in Japan

Japan |  News | 0 Comment | 27 Jan, 2020

Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-hous...Read more

Japan Ministry approves Propess for cervical ripening

Japan |  News | 0 Comment | 23 Jan, 2020

Swiss firm Ferring Pharmaceuticals has announced that Propess® (dinoprostone) has been approved by the Minister...Read more

Poxel appoints industry leader Dr. David E. Moller as CSO

Japan |  News | 0 Comment | 23 Jan, 2020

POXEL, headquartered France, and with subsidiaries in Japan, is a biopharmaceutical company focused on the development o...Read more

Darolutamide gets marketing authorization in Japan

Japan |  News | 0 Comment | 24 Jan, 2020

The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...Read more